Clinical trial
Reversal of Atrial Substrate to Prevent Atrial Fibrillation
NCT03682991 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversal of Atrial Substrate to Prevent Atrial Fibrillation
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 1, 2019
- Completion date
- December 31, 2027
- Enrollment
- 509 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.